Loading company
Moderna, Inc.
MRNA · Nasdaq · ·
Next earnings: November 5, 2026
$203.44+3.1%Sep 29 close
- 1M
- +47.4%
- 6M
- +321.8%
- 1Y
- +687.6%
- 5Y
- -50.2%
MRNA · Nasdaq · ·
Next earnings: November 5, 2026
$203.44+3.1%Sep 29 close
Moderna, Inc. is scheduled to report next on November 5, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $145M | $142M | +2.11% |
| Profit | -$782M | -$825M | +5.21% |
| Profit per share | -$1.97 | -$2.13 | +7.51% |
| Free Cash Flow | -$563M | -$922M | +38.94% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Moderna, Inc.’s Item 2.02 8-K filed July 31, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Moderna, Inc. has no earnings call transcript available.